In summary, we report that pharmacological blockade of NHE1 protein in combination with TMZ increases myeloid cell tumor infiltration, stimulates glucose uptake and mitochondrial glucose metabolism in GAMs and tumor-infiltrating T-cells in a mouse GBM model (Fig. 6C). The gene discussed is SLC9A1; the disease is glioblastoma.